186 related articles for article (PubMed ID: 22328516)
1. The metastasis gene NEDD9 product acts through integrin β3 and Src to promote mesenchymal motility and inhibit amoeboid motility.
Ahn J; Sanz-Moreno V; Marshall CJ
J Cell Sci; 2012 Apr; 125(Pt 7):1814-26. PubMed ID: 22328516
[TBL] [Abstract][Full Text] [Related]
2. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
[TBL] [Abstract][Full Text] [Related]
3. The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC.
Sima N; Cheng X; Ye F; Ma D; Xie X; Lü W
PLoS One; 2013; 8(9):e74594. PubMed ID: 24058594
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells.
Dai J; Van Wie PG; Fai LY; Kim D; Wang L; Poyil P; Luo J; Zhang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():106-112. PubMed ID: 27664007
[TBL] [Abstract][Full Text] [Related]
5. Rac activation and inactivation control plasticity of tumor cell movement.
Sanz-Moreno V; Gadea G; Ahn J; Paterson H; Marra P; Pinner S; Sahai E; Marshall CJ
Cell; 2008 Oct; 135(3):510-23. PubMed ID: 18984162
[TBL] [Abstract][Full Text] [Related]
6. Integrin alphavbeta3 mediates K1735 murine melanoma cell motility in vivo and in vitro.
Li X; Regezi J; Ross FP; Blystone S; Ilić D; Leong SP; Ramos DM
J Cell Sci; 2001 Jul; 114(Pt 14):2665-72. PubMed ID: 11683393
[TBL] [Abstract][Full Text] [Related]
7. NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.
Jin Y; Li F; Zheng C; Wang Y; Fang Z; Guo C; Wang X; Liu H; Deng L; Li C; Wang H; Chen H; Feng Y; Ji H
Int J Cancer; 2014 May; 134(10):2294-304. PubMed ID: 24174333
[TBL] [Abstract][Full Text] [Related]
8. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
[TBL] [Abstract][Full Text] [Related]
9. Src kinase determines the dynamic exchange of the docking protein NEDD9 (neural precursor cell expressed developmentally down-regulated gene 9) at focal adhesions.
Bradbury P; Bach CT; Paul A; O'Neill GM
J Biol Chem; 2014 Sep; 289(36):24792-800. PubMed ID: 25059660
[TBL] [Abstract][Full Text] [Related]
10. NEDD9 stabilizes focal adhesions, increases binding to the extra-cellular matrix and differentially effects 2D versus 3D cell migration.
Zhong J; Baquiran JB; Bonakdar N; Lees J; Ching YW; Pugacheva E; Fabry B; O'Neill GM
PLoS One; 2012; 7(4):e35058. PubMed ID: 22509381
[TBL] [Abstract][Full Text] [Related]
11. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
[TBL] [Abstract][Full Text] [Related]
12. NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7.
Wang Z; Shen M; Lu P; Li X; Zhu S; Yue S
Oncotarget; 2017 Jan; 8(1):1714-1724. PubMed ID: 27974675
[TBL] [Abstract][Full Text] [Related]
13. Regulating the conversion between rounded and elongated modes of cancer cell movement.
Croft DR; Olson MF
Cancer Cell; 2008 Nov; 14(5):349-51. PubMed ID: 18977323
[TBL] [Abstract][Full Text] [Related]
14. PP2A phosphatase suppresses function of the mesenchymal invasion regulator NEDD9.
Bradbury P; Mahmassani M; Zhong J; Turner K; Paul A; Verrills NM; O'Neill GM
Biochim Biophys Acta; 2012 Feb; 1823(2):290-7. PubMed ID: 22061964
[TBL] [Abstract][Full Text] [Related]
15. NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
Gabbasov R; Xiao F; Howe CG; Bickel LE; O'Brien SW; Benrubi D; Do TV; Zhou Y; Nicolas E; Cai KQ; Litwin S; Seo S; Golemis EA; Connolly DC
Oncogene; 2018 Aug; 37(35):4854-4870. PubMed ID: 29773902
[TBL] [Abstract][Full Text] [Related]
16. Tumour invasion: a new twist on Rac-driven mesenchymal migration.
Sanz-Moreno V
Curr Biol; 2012 Jun; 22(11):R449-51. PubMed ID: 22677287
[TBL] [Abstract][Full Text] [Related]
17. NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.
Kong C; Wang C; Wang L; Ma M; Niu C; Sun X; Du J; Dong Z; Zhu S; Lu J; Huang B
PLoS One; 2011; 6(7):e22666. PubMed ID: 21829474
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade.
Rambow F; Bechadergue A; Luciani F; Gros G; Domingues M; Bonaventure J; Meurice G; Marine JC; Larue L
J Invest Dermatol; 2016 Jun; 136(6):1229-1237. PubMed ID: 26968260
[TBL] [Abstract][Full Text] [Related]
19. The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.
Margheri F; Luciani C; Taddei ML; Giannoni E; Laurenzana A; Biagioni A; Chillà A; Chiarugi P; Fibbi G; Del Rosso M
Oncotarget; 2014 Mar; 5(6):1538-53. PubMed ID: 24681666
[TBL] [Abstract][Full Text] [Related]
20. NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer.
Loskutov YV; Kozyulina PY; Kozyreva VK; Ice RJ; Jones BC; Roston TJ; Smolkin MB; Ivanov AV; Wysolmerski RB; Pugacheva EN
Oncogene; 2015 Jul; 34(28):3662-75. PubMed ID: 25241893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
